Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirini Thanopoulou

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Toxicology|July 1, 2011
The safety profile of imatinib in CML and GIST: long-term considerationsEirini Thanopoulou, Ian Judson
Expert Review of Anticancer Therapy|August 1, 2012
Hormonal therapy in gynecological sarcomasEirini Thanopoulou, Ian Judson
Clinical Sarcoma Research|July 15, 2014
Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitorsEirini Thanopoulou, Khin Thway, Komel Khabra, et al.
The New England Journal of Medicine|January 15, 2025
Inavolisib Therapy in Advanced Breast Cancer. ReplyNicholas C Turner, Eirini Thanopoulou, Komal L Jhaveri
Breast Cancer Research and Treatment|June 16, 2014
Pneumonitis and pulmonary fibrosis associated with breast cancer treatmentsClaudia Omarini, Eirini Thanopoulou, Stephen R D Johnston
Clinical Sarcoma Research|March 27, 2015
Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden HospitalEirini Thanopoulou, Aleksandar Aleksic, Khin Thway, et al.
Current Opinion in Pharmacology|May 14, 2013
Tumour heterogeneity and immune-modulationMariam Jamal-Hanjani, Eirini Thanopoulou, Karl S Peggs, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 8, 2012
The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancerEirini Thanopoulou, George Kotzamanis, Ioannis S Pateras, et al.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast CancerKomal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Toxicology|July 1, 2011
The safety profile of imatinib in CML and GIST: long-term considerationsEirini Thanopoulou, Ian Judson
Expert Review of Anticancer Therapy|August 1, 2012
Hormonal therapy in gynecological sarcomasEirini Thanopoulou, Ian Judson
Clinical Sarcoma Research|July 15, 2014
Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitorsEirini Thanopoulou, Khin Thway, Komel Khabra, et al.
The New England Journal of Medicine|January 15, 2025
Inavolisib Therapy in Advanced Breast Cancer. ReplyNicholas C Turner, Eirini Thanopoulou, Komal L Jhaveri
Breast Cancer Research and Treatment|June 16, 2014
Pneumonitis and pulmonary fibrosis associated with breast cancer treatmentsClaudia Omarini, Eirini Thanopoulou, Stephen R D Johnston
Clinical Sarcoma Research|March 27, 2015
Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden HospitalEirini Thanopoulou, Aleksandar Aleksic, Khin Thway, et al.
Current Opinion in Pharmacology|May 14, 2013
Tumour heterogeneity and immune-modulationMariam Jamal-Hanjani, Eirini Thanopoulou, Karl S Peggs, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 8, 2012
The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancerEirini Thanopoulou, George Kotzamanis, Ioannis S Pateras, et al.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast CancerKomal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
Pageof 2